Growth Metrics

Kiniksa Pharmaceuticals International (KNSA) Amortizatization of Intangibles: 2021-2025

Historic Amortizatization of Intangibles for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to -$603,000.

  • Kiniksa Pharmaceuticals International's Amortizatization of Intangibles fell 223.82% to -$603,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$833,000, marking a year-over-year decrease of 223.59%. This contributed to the annual value of -$441,000 for FY2024, which is 141.29% down from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Amortizatization of Intangibles stood at -$603,000 for Q3 2025, which was down 171.45% from $844,000 recorded in Q2 2025.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Amortizatization of Intangibles peaked at $1.2 million during Q2 2023, and registered a low of -$1.4 million during Q3 2023.
  • In the last 3 years, Kiniksa Pharmaceuticals International's Amortizatization of Intangibles had a median value of $188,000 in 2024 and averaged $55,727.
  • The largest annual percentage gain for Kiniksa Pharmaceuticals International's Amortizatization of Intangibles in the last 5 years was 1,615.79% (2023), contrasted with its biggest fall of 1,310.92% (2023).
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Amortizatization of Intangibles (Quarterly) stood at -$47,000 in 2021, then skyrocketed by 531.91% to $203,000 in 2022, then skyrocketed by 45.81% to $296,000 in 2023, then plummeted by 376.69% to -$819,000 in 2024, then tumbled by 223.82% to -$603,000 in 2025.
  • Its Amortizatization of Intangibles was -$603,000 in Q3 2025, compared to $844,000 in Q2 2025 and -$255,000 in Q1 2025.